title: Reply: Predictors of Bioresorbable Everolimus-Eluting Scaffold Failure at Intravascular Ultrasound Examination: Asymmetry Versus Expansion.
authors.forename: Pannipa
authors.initials: P
authors.lastname: Suwannasom
authors.forename: Yohei
authors.initials: Y
authors.lastname: Sotomi
authors.forename: Yoshinobu
authors.initials: Y
authors.lastname: Onuma
authors.forename: Patrick W
authors.initials: PW
authors.lastname: Serruys
mesh_terms: D020341:Absorbable Implants; D002317:Cardiovascular Agents; D054855:Drug-Eluting Stents; D000068338:Everolimus; D011474:Prosthesis Design; D020123:Sirolimus; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents; D000068338:Everolimus; D020123:Sirolimus